Table 2. Pre-treatment diagnostics.
Pt # | Disease | MRI: brain parenchyma | MRI: leptomeninges | Neurologic Symptoms | CSF Cytology | CSF mutant cfDNA (copies/μL) | Plasma/urine mutant cfDNA (copies/μL) |
---|---|---|---|---|---|---|---|
1 | Mel | + | + | - | - | 0.512 | P: 21 |
2 | Mel | + | - | + | - | 0 | P: 0.8 |
3 | Mel | + | - | + | - | 0.219 | P: 3.86 |
4 | Mel | + | - | + | - | 0 | P: 0 |
5 | Mel | + | - | + | - | 0.15 | P: 2.35 |
6 | Mel | - | + | + | + | 10.56 | No samples |
7 | Mel | + | + | + | + | 8.03 | No samples |
8 | Mel | - | - | + | - | 0 | P: 174 |
9 | ECD | - | - | + | - | 0 | U: 0.12 |
10 | ECD | - | - | + | - | 0.329 | P: 0.76 |
11 | ECD | + | - | + | - | 0 | P: .059 |
Mel: Melanoma, ECD: Erdheim-Chester Disease, P: Plasma, U: Urine.